GlassScriptPhysician profile
Yiqun Hui
NPI 1538490453
$5,252.36
in general payments reported to CMS, 2019-2025
17 companies · $1,040 in 2025
The $1,040 reported for 2025 was more than what a typical Allergy & Immunology (Internal Medicine) provider received nationally (typical 2025 total: $681).
See the full distribution for Allergy & Immunology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $859 · 2020: $543 · 2021: $632 · 2022: $746 · 2023: $675 · 2024: $758 · 2025: $1,040.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,372 · Education: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,372.43 |
| Education | $100.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,251.97 | 2019-2025 | Nucala, Trelegy Ellipta |
| Genzyme Corporation | $965.76 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $774.54 | 2019-2025 | Dupixent |
| Genentech USA, INC. | $670.93 | 2019-2025 | Xolair |
| Astrazeneca Pharmaceuticals LP | $505.02 | 2019-2025 | Tezspire, Airsupra, Breztri |
| Amgen INC. | $329.38 | 2021-2025 | Tezspire |
| Teva Pharmaceuticals USA, INC. | $177.69 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $140.62 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $96.38 | 2019 | |
| Alk-Abello, INC | $70.70 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $69.99 | 2025 | |
| Kaleo, INC. | $64.20 | 2019-2023 | Auvi-Q |
| Merck Sharp & Dohme LLC | $35.92 | 2021 | |
| Phadia US INC. | $35.43 | 2019-2020 | |
| Pfizer INC. | $30.54 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharming Healthcare, INC. | $19.87 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yiqun Hui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.